Glenmark Can't Nix Abbott's $16M Win Over Tarka Patent

Law360, New York (September 30, 2011, 6:40 PM EDT) -- A New Jersey federal judge on Friday rejected efforts by generic-drug maker Glenmark Pharmaceuticals Ltd. to overturn a jury’s $16 million judgment against it for allegedly infringing a patent licensed exclusively to Abbott Laboratories for the blood pressure drug Tarka.

A federal jury handed Abbott the victory in January, after the Chicago-based pharmaceutical company sued Glenmark over a generic version of Tarka, which is covered by a Sanofi-Aventis Deutschland GmbH-owned patent that is licensed exclusively to Abbott.

U.S. District Judge Dennis M. Cavanaugh denied Glenmark’s motions...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.